Parametric Portfolio Associates’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-17,008
Closed -$2.38M 4013
2018
Q4
$2.38M Sell
17,008
-4,711
-22% -$715K ﹤0.01% 2463
2018
Q3
$3.71M Sell
21,719
-5,090
-19% -$855K ﹤0.01% 2265
2018
Q2
$4.65M Buy
26,809
+3,330
+14% +$500K ﹤0.01% 2021
2018
Q1
$2.71M Buy
23,479
+9,335
+66% +$993K ﹤0.01% 2392
2017
Q4
$1.19M Sell
14,144
-12,193
-46% -$1.02M ﹤0.01% 2923
2017
Q3
$2.43M Sell
26,337
-6,042
-19% -$469K ﹤0.01% 2457
2017
Q2
$2.6M Sell
32,379
-5,300
-14% -$294K ﹤0.01% 2333
2017
Q1
$1.59M Buy
+37,679
New +$1.55M ﹤0.01% 2603
2016
Q3
Sell
-16,457
Closed -$381K 3819
2016
Q2
$381K Buy
16,457
+3,222
+24% +$80.2K ﹤0.01% 3340
2016
Q1
$362K Buy
+13,235
New +$277K ﹤0.01% 3505

Other funds holding LOXO

Parametric Portfolio Associates's LOXO Position: Q1 2019 in Review

Parametric Portfolio Associates sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 17,008 shares — an estimated $2.38M sold.

Parametric Portfolio Associates first reported a position in LOXO in Q1 2016 and held it in 10 quarters. The position peaked at $4.65M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Parametric Portfolio Associates reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 17,008 Loxo Oncology, Inc shares in Q1 2019, an estimated $2.38M.
  • Parametric Portfolio Associates first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 10 quarters.
  • Parametric Portfolio Associates's Loxo Oncology, Inc position peaked at $4.65M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Parametric Portfolio Associates's 13F filing for Q1 2019, filed 9 May 2019.